Arnaud Bayle

898 total citations
24 papers, 165 citations indexed

About

Arnaud Bayle is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arnaud Bayle has authored 24 papers receiving a total of 165 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arnaud Bayle's work include Cancer Genomics and Diagnostics (11 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Arnaud Bayle is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Arnaud Bayle collaborates with scholars based in France, Italy and Denmark. Arnaud Bayle's co-authors include Benjamin Besse, Étienne Rouleau, Solange Peters, Gracemarie Bricalli, Rosa Giuliani, Dan Chaltiel, Julia Bonastre, N.J. Latino, Antoîne Italiano and G. Charpentier and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Arnaud Bayle

20 papers receiving 162 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnaud Bayle France 8 72 64 51 26 21 24 165
Gökhan Uçar Türkiye 11 55 0.8× 83 1.3× 136 2.7× 28 1.1× 20 1.0× 42 254
Georges Gebrael United States 9 53 0.7× 113 1.8× 67 1.3× 41 1.6× 10 0.5× 53 235
Felicia Roncolato Australia 8 41 0.6× 55 0.9× 133 2.6× 59 2.3× 20 1.0× 31 247
Kenneth Elder Australia 8 69 1.0× 25 0.4× 108 2.1× 27 1.0× 41 2.0× 19 230
Nandini Menon India 9 31 0.4× 102 1.6× 107 2.1× 36 1.4× 5 0.2× 46 238
Eric Brown United States 9 72 1.0× 23 0.4× 40 0.8× 24 0.9× 85 4.0× 16 206
Dilyara Kaidarova Kazakhstan 8 40 0.6× 37 0.6× 92 1.8× 43 1.7× 31 1.5× 61 211
Xin Song China 9 21 0.3× 42 0.7× 54 1.1× 30 1.2× 21 1.0× 28 226
Giovanni Maria Iannantuono Italy 9 32 0.4× 76 1.2× 69 1.4× 36 1.4× 10 0.5× 23 237
Yin Liu China 8 27 0.4× 34 0.5× 57 1.1× 33 1.3× 10 0.5× 32 185

Countries citing papers authored by Arnaud Bayle

Since Specialization
Citations

This map shows the geographic impact of Arnaud Bayle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Bayle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Bayle more than expected).

Fields of papers citing papers by Arnaud Bayle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Bayle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Bayle. The network helps show where Arnaud Bayle may publish in the future.

Co-authorship network of co-authors of Arnaud Bayle

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud Bayle. A scholar is included among the top collaborators of Arnaud Bayle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud Bayle. Arnaud Bayle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Timens, Wim, Arnaud Bayle, Luka Brčić, et al.. (2024). Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer. The Lancet Regional Health - Europe. 38. 100839–100839. 23 indexed citations
2.
Boulin, Mathieu, Claire Falandry, Laure de Decker, et al.. (2023). Enhancing collaboration between geriatricians, oncologists, and pharmacists to optimize medication therapy in older adults with cancer: A position paper from SOFOG-SFPO. Critical Reviews in Oncology/Hematology. 190. 104117–104117. 5 indexed citations
3.
Bayle, Arnaud, Julia Bonastre, Dan Chaltiel, et al.. (2023). ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe. Annals of Oncology. 34(10). 934–945. 51 indexed citations
4.
Smolenschi, Cristina, Antoine Hollebecque, Damien Vasseur, et al.. (2023). 1659P The use of liquid biopsy in patients with advanced pancreatic cancer (PDAC) to guide enrollment in phase I clinical trials. Annals of Oncology. 34. S913–S914. 1 indexed citations
5.
Horgan, Denis, Dario Trapani, Umberto Malapelle, et al.. (2023). Clouds across the new dawn for clinical, diagnostic and biological data: accelerating the development, delivery and uptake of personalized medicine. Diagnosis. 10(4). 356–362. 2 indexed citations
6.
Boilève, Alice, Matthieu Faron, Arnaud Bayle, et al.. (2023). Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data. European Journal of Cancer. 186. 122–132. 7 indexed citations
7.
Parisi, Claudia, Marco Tagliamento, Mihaela Aldea, et al.. (2023). Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applications. SHILAP Revista de lepidopterología. 1. 100007–100007. 10 indexed citations
8.
Bayle, Arnaud, Damien Vasseur, Claudio Nicotra, et al.. (2023). Clinical utility of plasma ctDNA sequencing in metastatic urothelial carcinoma.. Journal of Clinical Oncology. 41(16_suppl). 4576–4576. 1 indexed citations
9.
Dien, Alicia Tran, L. Mignot, Martina Pagliuca, et al.. (2023). 29P Prevalence of high tumor mutational burden (TMB) in patients with metastatic breast cancer (mBC) assessed by liquid biopsy (LB). ESMO Open. 8(1). 101253–101253. 2 indexed citations
10.
Bahleda, Rastilav, Aurore Vozy, Perrine Vuagnat, et al.. (2023). A self-assessment survey to identify the risk of screen failure in phase I clinical trials (SCITEP score).. Journal of Clinical Oncology. 41(16_suppl). e18725–e18725. 1 indexed citations
11.
Bayle, Arnaud, Damien Vasseur, Claudio Nicotra, et al.. (2023). Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancer. European Journal of Cancer. 195. 113368–113368. 13 indexed citations
12.
Hilmi, Marc, Alice Boilève, Arthur Géraud, et al.. (2022). Evaluation of supportive care needs, sexuality and quality of life in phase 1 trials: a prospective monocentric study. Supportive Care in Cancer. 30(12). 9841–9849.
13.
Bayle, Arnaud, Sophie Cousin, Lola‐Jade Palmieri, et al.. (2022). Genomic landscape of acquired resistance to targeted therapies in patients with solid tumors: A study from the National Center for Precision Medicine (PRISM).. Journal of Clinical Oncology. 40(16_suppl). 3016–3016.
14.
Sun, Roger, Samy Ammari, Sophie Bockel, et al.. (2021). Systematic Screening of COVID-19 Disease Based on Chest CT and RT-PCR for Cancer Patients Undergoing Radiation Therapy in a Coronavirus French Hotspot. International Journal of Radiation Oncology*Biology*Physics. 110(4). 947–956. 7 indexed citations
15.
Bayle, Arnaud, Debora Basile, Simon Garinet, et al.. (2021). Next-Generation Sequencing Targeted Panel in Routine Care for Metastatic Colon Cancers. Cancers. 13(22). 5750–5750. 3 indexed citations
16.
Baldini, Capucine, Stéphanie Foulon, Arnaud Bayle, et al.. (2020). Outcome of older cancer patients infected with Covid19 at Gustave Roussy Cancer Center. Clinical Cancer Research. 26(18). 2 indexed citations
17.
Baldini, Capucine, Stéphanie Foulon, Arnaud Bayle, et al.. (2020). 1688P Outcome of older cancer patients infected with COVID-19 at Gustave Roussy Cancer Center. Annals of Oncology. 31. S998–S998. 1 indexed citations
18.
Hueso, Thomas, Stéphanie Foulon, Laurence Albigès, et al.. (2020). Secondary haemophagocytic lymphohistiocytosis is a rare occurrence amongst cancer patients with COVID‐19. British Journal of Haematology. 192(3). e87–e90. 1 indexed citations
19.
Bayle, Arnaud, et al.. (2017). Prevention of chemotherapy-induced nausea and vomiting in patients receiving ifosfamide: High dose chemotherapy. European Journal of Cancer. 72. S156–S156.
20.
Varroud‐Vial, M., et al.. (1999). Cooperation between general practitioners and diabetologists and clinical audit improve the management of type 2 diabetic patients.. PubMed. 25(1). 55–63. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gökhan Uçar Breakdown of academic impact, for papers by Georges Gebrael Breakdown of academic impact, for papers by Felicia Roncolato Breakdown of academic impact, for papers by Kenneth Elder Breakdown of academic impact, for papers by Nandini Menon Breakdown of academic impact, for papers by Eric Brown Breakdown of academic impact, for papers by Dilyara Kaidarova Breakdown of academic impact, for papers by Xin Song Breakdown of academic impact, for papers by Giovanni Maria Iannantuono Breakdown of academic impact, for papers by Yin Liu
Rankless by CCL
2026